x

Sciences

Greece Receives First 2,000 Doses of Regeneron Drug against COVID

November 10, 2021

ATHENS – The first 2,000 doses of the drug against Covid-19 by companies Regeneron-Roche were received by Greece’s Pharmaceutical Research & Technology Company (IFET S.A.) on Wednesday.

The drug, which is based on monoclonal antibodies, is becoming available in Greece for the first time by IFET, in the context of the country’s participation in EU’s program for the provision of this new therapy.

In an announcement by IFET, it was clarified that the goal of this treatment is to prevent the worsening of the disease, while treatment of patients will be based on criteria that are expected to be determined by relevant health authorities soon.

RELATED

ATHENS - A Mixed Jury Criminal Appeals Court on Friday handed down sentences of life and 15 years imprisonment on the two young men found guilty of the murder and gang rape of 21-year-old student Eleni Topaloudi, imposing the same sentence as that imposed by a lower court.

Top Stories

General News

FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

General News

PHILADELPHIA – The Federation of Hellenic Societies of Philadelphia and Greater Delaware Valley announced that the Evzones, the Presidential Guard of Greece will be participating in the Philadelphia Greek Independence Day Parade on March 20.

Video

Mission, TNH’s New Travel Documentary Series with Clelia Charissis (Trailer)

Every weekend, TNH and Clelia Charissis are on a mission, traveling around Greece and the world to highlight places through the people we meet along the way.

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. abc@xyz.com

You may unsubscribe at any time using the link in our newsletter.